Gary Kelloff
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Papers in
-
- Inflammatory mediators and NSAID effects 4
- Pharmacogenetics and Drug Metabolism 1
- Oncology 4
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Bandaru S. Reddy (3 shared papers)Abraham Rivenson (3 shared papers)Chinthalapally V. Rao (3 shared papers)Vernon E. Steele (4 shared papers)Hiroko Maruyama (1 shared paper)Edith Zang (2 shared papers)Barbara Simi (1 shared paper)Leta Barnes (2 shared papers)
- Journals
- Carcinogenesis (4 papers)JCO Clinical Cancer Informatics (1 paper)Clinical Cancer Research (1 paper)Blood (1 paper)Oncology Reports (1 paper)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Gary Kelloff
11 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Pharmacology 746
- Cancer Research 277
- Biochemistry 116
- Genetics 379
- Psychiatry and Mental health 166
Countries citing papers authored by Gary Kelloff
This map shows the geographic impact of Gary Kelloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Kelloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Kelloff more than expected).
Fields of papers citing papers by Gary Kelloff
This network shows the impact of papers produced by Gary Kelloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Kelloff. The network helps show where Gary Kelloff may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Kelloff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. | 1995 | 373 |
| 2 | 1993 | 317 | |
| 3 | Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. | 1987 | 280 |
| 4 | 1994 | 201 | |
| 5 | 1994 | 53 | |
| 6 | 1996 | 39 | |
| 7 | Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5]pyridine-induced lymphoma formation by oltipraz. | 1996 | 30 |
| 8 | 2020 | 26 | |
| 9 | 2018 | 14 | |
| 10 | 2001 | 8 | |
| 11 | 2016 | 1 |
About Gary Kelloff
Gary Kelloff is a scholar working on Pharmacology, Oncology, Surgery, Cancer Research and Molecular Biology, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Estrogen and related hormone effects (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Pharmacology (746 citations), Cancer Research (277 citations), Biochemistry (116 citations), Genetics (379 citations) and Psychiatry and Mental health (166 citations). Gary Kelloff has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Bandaru S. Reddy, Abraham Rivenson, Chinthalapally V. Rao, Vernon E. Steele, Hiroko Maruyama, Edith Zang, Barbara Simi, Leta Barnes, Michael A. Pereira and Bandaru S. Reddy. Their work appears in journals such as Carcinogenesis, JCO Clinical Cancer Informatics, Clinical Cancer Research, Blood and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.